Skip to main navigation
Skip to search
Skip to main content
Illinois Experts Home
LOGIN & Help
Link opens in a new tab
Search content at Illinois Experts
Home
Profiles
Research units
Research & Scholarship
Datasets
Honors
Press/Media
Activities
Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum
Sumiti Vinayak
, Mattie C. Pawlowic
, Adam Sateriale
, Carrie F. Brooks
, Caleb J. Studstill
, Yael Bar-Peled
, Michael J. Cipriano
, Boris Striepen
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Genetic Modification
100%
Cryptosporidium
100%
Cryptosporidium Parvum
100%
Diarrheal Pathogens
100%
Sporozoite
50%
Young children
25%
Tissue Culture
25%
Transgenic
25%
Mouse Model
25%
AIDS/HIV
25%
Opportunistic Pathogens
25%
Drug Development
25%
Intestine
25%
Organ Transplantation
25%
Gene Knockout
25%
Continuous Culture
25%
Vaccine Development
25%
Tractability
25%
Rotavirus
25%
Graves
25%
Human Pathogens
25%
In Vivo Selection
25%
Protozoan Parasites
25%
Severe Diarrhea
25%
Immunocompromised Patients
25%
Approved Drugs
25%
Child Mortality
25%
Diarrheal Disease
25%
Cryptosporidiosis
25%
Molecular Genetic Tools
25%
Clustered Regularly Interspaced Short Palindromic repeats/Cas9
25%
Drug Susceptibility
25%
Child Patients
25%
Genetic Reporters
25%
Aminoglycoside Resistance
25%
In Vivo Drug Screening
25%
C. Parvum
25%
Immunology and Microbiology
Infectious Agent
100%
DNA Modification
100%
Cryptosporidium parvum
100%
Parasite
100%
Cryptosporidium
80%
Sporozoite
40%
Mouse Model
20%
Drug Screening
20%
Transgenics
20%
Gene Knockout
20%
Tissue Culture
20%
Gene Targeting
20%
Intestine
20%
Genetic Transfection
20%
Human Immunodeficiency Virus
20%
Continuous Culture
20%
Rotavirus
20%
Human Pathogen
20%
Protozoa
20%
Clustered Regularly Interspaced Short Palindromic Repeat
20%
Organ Transplantation
20%
Immunocompromised Patient
20%
Drug Sensitivity
20%
Childhood Mortality
20%
Acquired Immune Deficiency Syndrome
20%
In Vitro
20%